|
|
Gene Symbol |
IL5 |
|
Aliases |
EDF, IL-5, TRF |
|
Entrez Gene ID |
|
|
Gene Name |
Interleukin 5 |
|
Chromosomal Location |
5q31.1 |
|
HGNC ID |
|
|
Summary |
This gene encodes a cytokine that acts as a growth and differentiation factor for both B cells and eosinophils. The encoded cytokine plays a major role in the regulation of eosinophil formation, maturation, recruitment and survival. The increased production of this cytokine may be related to pathogenesis of eosinophil-dependent inflammatory diseases. This cytokine functions by binding to its receptor, which is a heterodimer, whose beta subunit is shared with the receptors for interleukine 3 (IL3) and colony stimulating factor 2 (CSF2/GM-CSF). This gene is located on chromosome 5 within a cytokine gene cluster which includes interleukin 4 (IL4), interleukin 13 (IL13), and CSF2 . This gene, IL4, and IL13 may be regulated coordinately by long-range regulatory elements spread over 120 kilobases on chromosome 5q31. [provided by RefSeq, Jul 2013]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Protein Information |
|
Protein Name |
Interleukin-5, B-cell differentiation factor I, T-cell replacing factor, colony-stimulating factor, eosinophil, eosinophil differentiation factor |
|
Function |
Factor that induces terminal differentiation of late-developing B-cells to immunoglobulin secreting cells |
|
|
|
|
|
UniProt |
|
|
PDB |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000219070 |
P08253 |
P08253 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Blood Disorders |
Eosinophilia |
|
Endocrine System Diseases |
PCOS |
|
Immune System Diseases |
Dermatitis |
|
Autoimmune Hepatitis |
|
Psychiatric/Brain disorders |
Autistic Disorder |
|
Respiratory Tract Diseases |
Pulmonary Fibrosis |
|
Asthma |
|
Skin and Connective Tissue Diseases |
Eczema |
|
Dermatitis |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
IL-6,stimulated production of IFN-gamma, IL-2, IL-4, TNF-alpha ,IL-10, leukocyte numbers and hsCRP |
Cardiovascular risk,obesity and inflammation |
|
|
Related
|
|
The stimulated production of IFN-gamma, TNF-alpha, IL-2, IL-4, and IL-5 was significantly decreased, irrespective of BMI. |
|
|
|
|